Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia	Agitation Associated With Alzheimer's Disease Dementia	Recruiting	Phase 2 / Phase 3	2026-08-14		NCT07284472

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Exciva GmbH	1

49 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Azienda Ospedaliera Cardinale Giovanni Panico	Tricase	Italy	1
Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone	Palermo	Italy	8
Azienda Ospedaliera Universitaria Policlinico Tor Vergata	Rome	Italy	2
Baycrest Centre for Geriatric Care	North York	Canada	1
Brain-Soultherapy s.r.o.	Kladno	Czechia	1
Centrum Medyczne HCP Sp. z o.o.	Poznan	Poland	2
Clinhouse Sp. z o.o.	Zabrze	Poland	1
Crystal Comfort S.R.O.	Vranov nad Topľou	Slovakia	1
Curiositas ad sanum Studien und Beratungs GmbH	Ebersberg	Germany	1
EPAMED s r.o.	Košice	Slovakia	1
Esperanza Clinical	Murrieta	United States	6
ETG Neuroscience Sp. z o.o.	Warsaw	Poland	1
FNUSA - St. Anne's University Hospital Brno	Brno	Czechia	1
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico - Main Campus	Milan	Italy	1
FutureMeds Wroclaw	Wroclaw	Poland	1
Galen Research LLC	Chesterfield	United States	1
Hospital Clinico San Carlos	Madrid	Spain	103
Hospital Universitari Germans Trias i Pujol	Barcelona	Spain	1
Hospital Universitario Rio Hortega	Valladolid	Spain	1
Hospital Universitario Virgen de la Macarena	Seville	Spain	1
Hospital Virgen de la Concha	Zamora	Spain	1
Insight Clinical Trials	Independence	United States	5
Integrative Clinical Trials	Brooklyn	United States	3
IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli	Brescia	Italy	3
Josephson Wallack Munshower Neurology PC	Indianapolis	United States	1

Clinical trials